Article
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
10 Oct 2019
Abstract excerpt
Immunotherapy has emerged as the new therapeutic frontier of cancer treatment, showing enormous survival benefits in multiple tumor diseases. Although undeniable success has been observed in clinical trials, not all patients respond to treatment. Different concurrent conditions can attenuate or completely abrogate the usefulness of immunotherapy due to the activation of several escape mechanisms. Indeed, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
